Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CFSB Bancorp Inc | Michael E. McFarland | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 64,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Susan J. Shea | Treasurer and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 48,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Michael E. McFarland | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 24,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Paul N. Baharian | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 19,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Susan J. Shea | Treasurer and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 18,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Michael E. McFarland | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 17,999 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | James M. O’Leary | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 16,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Robert Guarnieri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 16,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | James M. O’Leary | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Paul N. Baharian | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Robert Guarnieri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Edward J. Keohane | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Stephen D. Marini | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Tracy L. Wilson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | William R. Esselstyn | VP-Information Systems | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Mary Kuropatkin | VP-Retail Banking | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Angela M. Blanchard | VP-Retail Lending | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 14,000 | 0 | - | - | Stock Options | |
| CFSB Bancorp Inc | Angela M. Blanchard | VP-Retail Lending | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 12,540 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | William R. Esselstyn | VP-Information Systems | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 11,940 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Tracy L. Wilson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 11,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Susan J. Shea | Treasurer and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 10,923 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Edward J. Keohane | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 10,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Stephen D. Marini | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 10,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Mary Kuropatkin | VP-Retail Banking | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 9,940 | 0 | - | - | Common Stock | |
| AllianceBernstein National | Garry L. Moody | Director | Purchase of securities on an exchange or from another person at price $ 11.08 per share. | 31 Oct 2025 | 9,000 | 9,000 (0%) | 0% | 11.1 | 99,720 | Common Stock |
| CFSB Bancorp Inc | Paul N. Baharian | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 6,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Edward J. Keohane | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 6,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Stephen D. Marini | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 6,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | William R. Esselstyn | VP-Information Systems | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 6,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Mary Kuropatkin | VP-Retail Banking | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 6,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Angela M. Blanchard | VP-Retail Lending | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 6,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | James M. O’Leary | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 5,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Michael E. McFarland | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 5,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Edward J. Keohane | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 5,000 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Stephen D. Marini | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 5,000 | 0 | - | - | Common Stock | |
| AllianceBernstein National | Garry L. Moody | Director | Purchase of securities on an exchange or from another person at price $ 11.06 per share. | 31 Oct 2025 | 4,500 | 13,500 (0%) | 0% | 11.1 | 49,787 | Common Stock |
| CFSB Bancorp Inc | Michael E. McFarland | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 4,215 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Susan J. Shea | Treasurer and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 3,147 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Robert Guarnieri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 2,500 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Susan J. Shea | Treasurer and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 2,500 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Mary Kuropatkin | VP-Retail Banking | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 2,381 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | William R. Esselstyn | VP-Information Systems | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 2,351 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Angela M. Blanchard | VP-Retail Lending | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 2,191 | 0 | - | - | Common Stock | |
| Astec Industries Inc | Jeffrey T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 401 | 8,788 (0%) | 0% | 0 | Common Stock | |
| CFSB Bancorp Inc | William R. Esselstyn | VP-Information Systems | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 350 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | William R. Esselstyn | VP-Information Systems | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 200 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Tracy L. Wilson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 100 | 0 | - | - | Common Stock | |
| CFSB Bancorp Inc | Tracy L. Wilson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 100 | 0 | - | - | Common Stock | |
| Welltower - REIT | Shankh S. Mitra | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,485,146 | 2,485,146 | - | - | LTIP Units | |
| Welltower - REIT | Shankh S. Mitra | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,485,146 | 2,485,146 | - | - | Other Stock Units | |
| CoreCard Corporation Ordinary | J. Leland Strange | Director, President & CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 1,310,037 | 0 (0%) | 14% | - | Common stock, par value $.01 per share | |
| Alpha Modus Holdings Inc | William Alessi | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 430,000 | 3,870,000 | - | - | Series C Preferred Stock | |
| Alpha Modus Holdings Inc | Christopher Phillip Chumas | Chief Sales Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 215,000 | 215,000 | - | - | Series C Preferred Stock | |
| Alpha Modus Holdings Inc | Christopher Phillip Chumas | Chief Sales Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 215,000 | 430,000 | - | - | Series C Preferred Stock | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 200,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 30 Oct 2025 | 200,000 | 779,925 (3%) | 0% | 2.9 | 584,000 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.06 per share. | 30 Oct 2025 | 169,439 | 610,486 (2%) | 0% | 4.1 | 687,922 | Common Stock |
| Avantor Inc | Gregory L. Summe | Director | Purchase of securities on an exchange or from another person at price $ 11.25 per share. | 30 Oct 2025 | 100,000 | 300,000 (0%) | 0% | 11.3 | 1,125,000 | Common Stock |
| Amrize Registered Shares | Jan Philipp Jenisch | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 52.64 per share. | 30 Oct 2025 | 55,000 | 1,505,000 | - | 52.6 | 2,895,200 | Ordinary Shares |
| Amrize Registered Shares | Jan Philipp Jenisch | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 52.88 per share. | 30 Oct 2025 | 55,000 | 505,000 | - | 52.9 | 2,908,400 | Ordinary Shares |
| UiPath Inc Ordinary Shares | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 30 Oct 2025 | 45,000 | 29,468,585 | - | 15.7 | 707,643 | Class A Common Stock |
| Universal Insurance Holdings | Jon W. Springer | Director | Sale of securities on an exchange or to another person at price $ 31.41 per share. | 30 Oct 2025 | 35,435 | 271,628 (0%) | 0% | 31.4 | 1,113,081 | Common Stock |
| CoreCard Corporation Ordinary | Matthew A. White | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | A. Russell Chandler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 29,617 | 0 (0%) | 0% | - | Common stock, par value $.01 per share | |
| Booz Allen Hamilton Holding | Horacio D. Rozanski | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 84.66 per share. | 30 Oct 2025 | 23,800 | 687,745 (0%) | 0% | 84.7 | 2,014,908 | Class A Common Stock |
| Impinj Inc | Chris Diorio | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 23,500 | 0 | - | - | Stock Option (right to buy) | |
| Impinj Inc | Chris Diorio | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.40 per share. | 30 Oct 2025 | 23,500 | 378,005 (1%) | 0% | 22.4 | 526,400 | Common Stock |
| Brandywine Realty Trust | James C. Diggs | Director | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 30 Oct 2025 | 23,190 | 128,672 (0%) | 0% | 3.5 | 80,469 | Common Shares of Beneficial Interest |
| Verra Mobility Corp Ordinary | Jonathan Keyser | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 12,771 | 12,771 | - | - | Restricted Stock Units | |
| NBT Bancorp Inc | David J. Nasca | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 12,255 | 70,655 (0%) | 0% | 0 | NBT Bancorp Inc. Common Stock | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 30 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 11,000 | 22,000 | - | - | Stock Option | |
| Xylem | Claudia S. Toussaint | EVP, CPSO | Sale of securities on an exchange or to another person at price $ 152.64 per share. | 30 Oct 2025 | 10,421 | 31,250 (0%) | 0% | 152.6 | 1,590,661 | Common Stock |
| JBG SMITH Properties | Scott A. Estes | Director | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 30 Oct 2025 | 10,000 | 20,000 (0%) | 0% | 19.9 | 198,700 | Common Shares |
| CoreCard Corporation Ordinary | Kathryn Petralia | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 9,812 | 0 (0%) | 0% | - | Common stock, par value $.01 per share | |
| CoreCard Corporation Ordinary | J. Leland Strange | Director, President & CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 8,125 | 0 | - | - | Restricted Stock Unit | |
| CoreCard Corporation Ordinary | Matthew A. White | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 8,125 | 0 | - | - | Restricted Stock Unit | |
| CoreCard Corporation Ordinary | Philip H. Moise | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 7,434 | 0 (0%) | 0% | - | Common stock, par value $.01 per share | |
| Cardlytics Inc | Srishti A. Gupta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,148 | 0 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Srishti A. Gupta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,148 | 6,148 (0%) | 0% | - | Common Stock | |
| CoreCard Corporation Ordinary | A. Russell Chandler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 62.86 per share. | 30 Oct 2025 | 5,000 | 358,108 (0%) | 0% | 62.9 | 314,300 | Common Stock |
| Annexon Inc | William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 30 Oct 2025 | 4,115 | 46,175 | - | 3.2 | 13,045 | Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 30 Oct 2025 | 4,087 | 76,751 | - | 12.8 | 52,300 | Common Stock |
| CoreCard Corporation Ordinary | A. Russell Chandler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | A. Russell Chandler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | Philip H. Moise | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | Philip H. Moise | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | Philip H. Moise | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | Philip H. Moise | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| CoreCard Corporation Ordinary | Matthew A. White | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 0 (0%) | 0% | - | Common stock, par value $.01 per share | |
| Western Alliance Bancorp | Dale M. Gibbons | Vice Chairman and CFO | Purchase of securities on an exchange or from another person at price $ 77.00 per share. | 30 Oct 2025 | 4,000 | 300,358 (0%) | 0% | 77 | 308,000 | Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 77,980 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 22,500 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 22,500 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 51,683 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 22,500 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 44,148 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 30 Oct 2025 | 3,644 | 50,897 | - | 12.8 | 46,631 | Common Stock |
| CoreCard Corporation Ordinary | J. Leland Strange | Director, President & CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 3,621 | 0 | - | - | Restricted Stock Unit | |
| CoreCard Corporation Ordinary | Matthew A. White | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 3,621 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 449.46 per share. | 30 Oct 2025 | 3,441 | 42,555 (0%) | 0% | 449.5 | 1,546,606 | Common Stock |
| Avidia Bancorp Inc | Robert D. Cozzone | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 15.03 per share. | 30 Oct 2025 | 3,325 | 46,472 | - | 15.0 | 49,987 | Common Stock |
| Wesbanco Inc | Zahid Afzal | Director | Purchase of securities on an exchange or from another person at price $ 30.11 per share. | 30 Oct 2025 | 3,319 | 13,221 (0%) | 0% | 30.1 | 99,940 | Common Stock |
| Celestica Inc | Laurette T. Koellner | Director | Purchase of securities on an exchange or from another person at price $ 341.96 per share. | 30 Oct 2025 | 3,227 | 4,527 (0%) | 0% | 342.0 | 1,103,505 | Common Shares |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,207 | 72,230 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,207 | 3,207 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 30 Oct 2025 | 3,130 | 43,876 | - | 12.8 | 40,054 | Common Stock |
| Integer Holdings Corp | Payman Khales | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 64.94 per share. | 30 Oct 2025 | 3,127 | 22,865 (0%) | 0% | 64.9 | 203,067 | Common Stock |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,886 | 38,398 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,886 | 2,887 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 28,584 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 80,838 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 28,584 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 54,541 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 28,584 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 47,006 | - | 0 | Common Stock | |
| Corning Incorporated | Jaymin Amin | SVP and Chief Tech. Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 2,650 | 86,072 (0%) | 0% | 0 | Common Stock | |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 161.01 per share. | 30 Oct 2025 | 2,501 | 323,880 (0%) | 0% | 161.0 | 402,688 | Class A Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 161.01 per share. | 30 Oct 2025 | 2,500 | 325,195 (0%) | 0% | 161.0 | 402,527 | Class A Common Stock |
| Comerica Inc | Melinda A. Chausse | Sr EVP & Chief Credit Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,450 | 0 | - | - | Employee Stock Option (right to buy) | |
| Comerica Inc | Melinda A. Chausse | Sr EVP & Chief Credit Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.97 per share. | 30 Oct 2025 | 2,450 | 62,736 (0%) | 0% | 33.0 | 80,777 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 450.64 per share. | 30 Oct 2025 | 2,247 | 40,308 (0%) | 0% | 450.6 | 1,012,579 | Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 162.26 per share. | 30 Oct 2025 | 2,031 | 321,930 (0%) | 0% | 162.3 | 329,548 | Class A Common Stock |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 162.26 per share. | 30 Oct 2025 | 2,030 | 326,381 (0%) | 0% | 162.3 | 329,386 | Class A Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 74,230 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 4,000 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 4,000 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 47,933 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 40,398 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 4,000 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 1,924 | 45,933 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 1,924 | 1,925 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 451.57 per share. | 30 Oct 2025 | 1,849 | 38,459 (0%) | 0% | 451.6 | 834,952 | Common Stock |
| Farmers National Banc Corp | Gina A Richardson | Director | Purchase of securities on an exchange or from another person at price $ 12.99 per share. | 30 Oct 2025 | 1,833 | 13,823 (0%) | 0% | 13.0 | 23,811 | Farmers National Banc Corp |
| Third Coast Bancshares Inc | Troy A. Glander | Director | Sale of securities on an exchange or to another person at price $ 36.96 per share. | 30 Oct 2025 | 1,706 | 28,833 | - | 37.0 | 63,057 | Common Stock |
| Comerica Inc | Melinda A. Chausse | Sr EVP & Chief Credit Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.09 per share. | 30 Oct 2025 | 1,600 | 61,136 (0%) | 0% | 77.1 | 123,344 | Common Stock |
| Guggenheim Strategic | Randall Barnes | Director, TRUSTEE | Purchase of securities on an exchange or from another person at price $ 13.02 per share. | 30 Oct 2025 | 1,580 | 1,580 (0%) | 0% | 13.0 | 20,572 | Common Stock |
| MidWestOne Financial Group Inc | Charles N. Reeves | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 36.67 per share. | 30 Oct 2025 | 1,550 | 60,542 (0%) | 0% | 36.7 | 56,838 | Common Stock |
| Celestica Inc | Laurette T. Koellner | Director | Purchase of securities on an exchange or from another person at price $ 342.44 per share. | 30 Oct 2025 | 1,473 | 6,000 (0%) | 0% | 342.4 | 504,414 | Common Shares |
| MidWestOne Financial Group Inc | Charles N. Reeves | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 36.48 per share. | 30 Oct 2025 | 1,450 | 61,992 (0%) | 0% | 36.5 | 52,900 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 452.33 per share. | 30 Oct 2025 | 1,285 | 37,174 (0%) | 0% | 452.3 | 581,243 | Common Stock |
| Serve Robotics Inc | Brian Read | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.32 per share. | 30 Oct 2025 | 1,270 | 353,827 | - | 13.3 | 16,916 | Common Stock |
| Academy Sports and Outdoors | Kenneth C. Hicks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 1,245 | 450,441 | - | - | Common Stock | |
| Academy Sports and Outdoors | Kenneth C. Hicks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 1,245 | 7,781 | - | - | Restricted Stock Units | |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.12 per share. | 30 Oct 2025 | 1,150 | 322,730 (0%) | 0% | 164.1 | 188,742 | Class A Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.12 per share. | 30 Oct 2025 | 1,150 | 328,195 (0%) | 0% | 164.1 | 188,742 | Class A Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 448.56 per share. | 30 Oct 2025 | 1,143 | 45,996 (0%) | 0% | 448.6 | 512,706 | Common Stock |
| CSW Industrials Inc | Joseph B. Armes | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 30 Oct 2025 | 1,000 | 66,493 (0%) | 0% | 250 | 250,000 | Common Stock |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.14 per share. | 30 Oct 2025 | 800 | 321,930 (0%) | 0% | 163.1 | 130,508 | Class A Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.14 per share. | 30 Oct 2025 | 800 | 323,961 (0%) | 0% | 163.1 | 130,508 | Class A Common Stock |
| P&G | Matthew W. Janzaruk | SVP - Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 149.57 per share. | 30 Oct 2025 | 725 | 978 (0%) | 0% | 149.6 | 108,438 | Common Stock |
| Celestica Inc | Laurette T. Koellner | Director | Purchase of securities on an exchange or from another person at price $ 339.68 per share. | 30 Oct 2025 | 700 | 700 (0%) | 0% | 339.7 | 237,776 | Common Shares |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 447.34 per share. | 30 Oct 2025 | 642 | 47,139 (0%) | 0% | 447.3 | 287,195 | Common Stock |
| Celestica Inc | Laurette T. Koellner | Director | Purchase of securities on an exchange or from another person at price $ 340.55 per share. | 30 Oct 2025 | 600 | 1,300 (0%) | 0% | 340.6 | 204,330 | Common Shares |
| Trane Tech | Elizabeth A. Elwell | VP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.97 per share. | 30 Oct 2025 | 600 | 7,748 (0%) | 0% | 79.0 | 47,382 | Ordinary Shares |
| Trane Tech | Elizabeth A. Elwell | VP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 600 | 3,201 | - | - | Stock Option (Right to Buy) | |
| Trane Tech | Elizabeth A. Elwell | VP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 440.00 per share. | 30 Oct 2025 | 600 | 7,148 (0%) | 0% | 440 | 264,000 | Ordinary Shares |
| Academy Sports and Outdoors | Kenneth C. Hicks | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.84 per share. | 30 Oct 2025 | 589 | 449,852 | - | 48.8 | 28,767 | Common Stock |
| Honeywell | Rose Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Oct 2025 | 580 | 0 | - | - | Restricted Stock Units | |
| WD40 Co | David B. Pendarvis | Director | Purchase of securities on an exchange or from another person at price $ 196.37 per share. | 30 Oct 2025 | 523 | 5,862 (0%) | 0% | 196.4 | 102,702 | Common Stock |
| Horizon Bancorp Inc IN | Vanessa P. Williams | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 500 | 9,476 (0%) | 0% | 0 | Common Stock | |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 159.08 per share. | 30 Oct 2025 | 500 | 328,411 (0%) | 0% | 159.1 | 79,540 | Class A Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 159.08 per share. | 30 Oct 2025 | 500 | 327,695 (0%) | 0% | 159.1 | 79,540 | Class A Common Stock |
| WD40 Co | Eric P Etchart | Director | Purchase of securities on an exchange or from another person at price $ 194.02 per share. | 30 Oct 2025 | 500 | 8,370 (0%) | 0% | 194.0 | 97,010 | Common Stock |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 160.09 per share. | 30 Oct 2025 | 434 | 328,911 (0%) | 0% | 160.1 | 69,480 | Class A Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 160.09 per share. | 30 Oct 2025 | 434 | 324,761 (0%) | 0% | 160.1 | 69,481 | Class A Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 454.15 per share. | 30 Oct 2025 | 393 | 36,781 (0%) | 0% | 454.1 | 178,480 | Common Stock |
| Bank7 Corp | Andrew J. Levinson | Regional President - Tulsa | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.64 per share. | 30 Oct 2025 | 291 | 47,088 (0%) | 0% | 41.6 | 12,117 | Common stock, par value $0.01 per share |
| Atlassian Corporation | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.88 per share. | 30 Oct 2025 | 250 | 329,345 (0%) | 0% | 157.9 | 39,469 | Class A Common Stock |
| Atlassian Corporation | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.88 per share. | 30 Oct 2025 | 250 | 329,345 (0%) | 0% | 157.9 | 39,469 | Class A Common Stock |
| Millrose Properties Inc | Rachel Presa | General Counsel and Secretary | Purchase of securities on an exchange or from another person at price $ 32.37 per share. | 30 Oct 2025 | 242 | 1,468 | - | 32.4 | 7,834 | Class A Common Stock |
| Nicolet Bankshares Inc | Hubert Phillip Moore | CFO | Purchase of securities on an exchange or from another person at price $ 115.84 per share. | 30 Oct 2025 | 240 | 32,947 (0%) | 0% | 115.8 | 27,802 | Common Stock |
| Millrose Properties Inc | Rachel Presa | General Counsel and Secretary | Purchase of securities on an exchange or from another person at price $ 32.33 per share. | 30 Oct 2025 | 234 | 1,226 | - | 32.3 | 7,565 | Class A Common Stock |
| Cummins | Mark Andrew Smith | VP - Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 449.10 per share. | 30 Oct 2025 | 200 | 31,582 (0%) | 0% | 449.1 | 89,819 | Common |
| Cummins | Mark Andrew Smith | VP - Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 200 | 13,110 | - | - | Stock Option (Right-to-Buy) | |
| Cummins | Mark Andrew Smith | VP - Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.12 per share. | 30 Oct 2025 | 200 | 31,782 (0%) | 0% | 142.1 | 28,424 | Common |
| Bakkt Holdings Inc Ordinary | Michael Alfred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 139 | 19,476 | - | 0 | Class A Common Stock | |
| Littelfuse Inc | Anthony Grillo | Director | Grant, award, or other acquisition of securities at price $ 242.83 per share. | 30 Oct 2025 | 103 | 74,330 (0%) | 0% | 242.8 | 25,011 | Common Stock |
| Barings Corporate Investors | Sears Merritt | Adviser Board Member | Other type of transaction at price $ 0.00 per share. | 30 Oct 2025 | 89 | 9,179 | - | - | MassMutual Non-Qualified Thrift Plan | |
| Valvoline Inc | Lori Ann Flees | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 54 | 10,266 | - | - | Deferred Stock Units | |
| Barings Corporate Investors | Christina Emery | President | Other type of transaction at price $ 0.00 per share. | 30 Oct 2025 | 35 | 4,855 | - | - | Barings Non-Qualified Thrift Plan | |
| Emcor Group Inc | Anthony J. Guzzi | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 12 | 207,316 (0%) | 0% | 0 | Common Stock | |
| Emcor Group Inc | Maxine Lum Mauricio | CAO, EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3 | 27,406 (0%) | 0% | 0 | Common Stock | |
| Emcor Group Inc | John W. Altmeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2 | 36,110 (0%) | 0% | 0 | Common Stock | |
| Wesbanco Inc | Zahid Afzal | Director | Purchase of securities on an exchange or from another person at price $ 30.00 per share. | 30 Oct 2025 | 2 | 13,223 (0%) | 0% | 30 | 60 | Common Stock |
| Emcor Group Inc | William P. Reid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 1 | 12,147 (0%) | 0% | 0 | Common Stock | |
| Emcor Group Inc | Jason R. Nalbandian | SVP, Chief Acct Officer & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 1 | 18,176 (0%) | 0% | 0 | Common Stock | |
| Valley National Bancorp | Jennifer W. Steans | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 868,890 | 0 (0%) | 0% | 0 | Common Stock | |
| Revelation Biosciences Inc | James Rolke | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 390,614 | 400,660 | - | 1.3 | 499,986 | Common Stock |
| Revelation Biosciences Inc | Chester S. Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 390,614 | 395,645 | - | 1.3 | 499,986 | Common Stock |
| Valley National Bancorp | Jennifer W. Steans | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 289,630 | 289,630 (0%) | 0% | 0 | Common Stock | |
| Frontier Group Holdings Inc | Jeffrey Mathew | SVP, Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2025 | 261,780 | 261,780 | - | - | Restricted Stock Units | |
| D.R. Horton | David V. Auld | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 191,667 | 1,007,339 (0%) | 0% | 0 | Common Stock | |
| D.R. Horton | David V. Auld | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 191,667 | 0 | - | - | Restricted Stock Unit | |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 149,992 | 213,679 (0%) | 0% | 0 | Common Stock | |
| Universal Health | Marc D. Miller | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.30 per share. | 29 Oct 2025 | 131,758 | 311,296 (0%) | 0% | 225.3 | 29,685,077 | Class B Common Stock |
| Amphenol | Lance E. D'Amico | Sr. VP, Secretary & GenCounsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 120,000 | 100,000 | - | - | Stock Option | |
| Amphenol | Lance E. D'Amico | Sr. VP, Secretary & GenCounsel | Sale of securities on an exchange or to another person at price $ 140.01 per share. | 29 Oct 2025 | 120,000 | 76,400 (0%) | 0% | 140.0 | 16,801,548 | Class A Common Stock |
| Amphenol | Lance E. D'Amico | Sr. VP, Secretary & GenCounsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.55 per share. | 29 Oct 2025 | 120,000 | 196,400 (0%) | 0% | 22.6 | 2,706,300 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.